White, ChristineChristineWhiteKeegan, HelenHelenKeeganPilkington, LorettoLorettoPilkingtonRuttle, CarmelCarmelRuttleKerr, PatrickPatrickKerrTurner, MichaelMichaelTurnerPrendiville, WalterWalterPrendivilleD'Arcy, TomTomD'ArcyO'Leary, John J.John J.O'LearyMartin, Cara M.Cara M.Martinet al.2018-01-242018-01-242013 Ameri2013-10European Journal of Clinical Microbiologyhttp://hdl.handle.net/10197/9202The clinical performance of the cobas human papillomavirus (HPV) test for detection of high-grade disease in a colposcopy-referred population was compared with that of Hybrid Capture 2 (HC2). The overall agreement between the tests was 92.3%. Clinical sensitivity and specificity for detection of cervical intraepithelial neoplasia grade 2 or greater (CIN2+) were 90.0% and 55.5% for cobas and 90.5% and 50.2% for HC2, respectively. In conclusion, both tests showed comparable performance for detection of CIN2+.enVirologyEvaluation of the clinical performance of the cobas® 4800 1 HPV test in a colposcopy referred populationClinical performance of the cobas 4800 HPV testJournal Article51103415341710.1128/JCM.01949-132017-09-14https://creativecommons.org/licenses/by-nc-nd/3.0/ie/